Hubungan Angka Neutrofil dengan Mortalitas Infark Miokard Akut
DOI:
https://doi.org/10.18196/mmjkk.v12i1.993Keywords:
Infark miokard akut, mortalitas, neutrofilia, Acute myocardial infarct, mortality, neutrophiliaAbstract
Infark Miokard Akut (IMA) adalah kondisi otot jantung yang tidak mendapatkan cukup darah dan oksigen. Jaringan yang mengalami infark dapat menimbulkan reaksi peradangan pada daerah perbatasan antara infark dengan jaringan hidup. Neutrofil dengan cepat memasuki daerah yang mati dan mulai melakukan penghancuran. Neutrofilia merupakan petanda inflamasi pada kejadian koroner akut dan mempunyai nilai prognostik. Belum ada penelitian yang spesifik pada angka neutrofil sebagai prediktor mortalitas infark miokard akut. Tujuan penelitian ini adalah untuk mengetahui hubungan angka neutrofil dengan mortalitas IMA. Jenis penelitian analitik observasional dengan desain studi kasus kontrol dengan menggunakan rekam medis di RS PKU Muhammadiyah Yogyakarta. Subjek yang memenuhi kriteria inklusi dan eksklusi dikelompokkan menjadi kelompok meninggal dan kelompok yang masih hidup. Didapatkan 146 sampel yang dibagi menjadi 2 kelompok, 38 orang dalam kelompok yang meninggal dan 108 orang untuk kelompok yang masih hidup. Hasil analisis dengan chi square menunjukkan tidak ada hubungan yang bermakna antara kelompok yang meninggal maupun yang masih hidup dengan nilai OR 1,476 (95% CI 0,65-3,22; p=0,368), sehingga dapat disimpulkan bahwa angka netrofil tidak berhubungan dengan mortalitas IMA.
Acute Myocardial Infarction (AMI) is an insufficiency of oxygen and blood in myocard. Infarction can induce inflammation reaction in borderline area of infarct and health tissue. Neutrophil enter to infarct area immediately and destroy. Neutrophilia is inflammation marker in acute coroner syndrome and have prognostic value. There is no a specific research about neutrophil as predictor of mortality of acute myocardial infarction. The objective research is to ascertain the relationship between neutrophil counts following acute myocardial infarction during hospitalization. An observational analytical research was done on AMI patients were hospitalized in the PKU Muhammadiyah Yogyakarta Hospital with case control design using medical records. Subject who fulfilled inclusion and exclusion criteria were divided into 2 groups, death group and live group. There were 146 samples which were divided into 2 groups, 38 patients in death group and 108 patients in live group. Chi square test showed that there is no significance statistically between death group and live group with OR 1,44 (95% CI 0,65-3,22; p=0,368). Neutrophil count does not related with mortality of AMI.
References
Fenton, D.E. 2008. Myocardial infarction. Diakses pada tanggal 3 April 2009 dari http:// emedicine.medscape.com/article/759321overview
Yahya, A.F. 2009. Terapi penyakit jantung koroner diakses pada tanggal 3 April 2009, dari http://huxleyi.wordpress.com/2009/02/02/ terapi-penyakit-jantung-koroner/
Brown, C.T. 2005. Penyakit aterosklerotik koroner. Dalam H. Hartanto, N. Susi, P.
Wulansari, & D.A. Mahanani (Ed.). Patofisiologi
Konsep Klinis Proses-proses Penyakit.
Jakarta:EGC (Original work published 2002)
Van Der Wal, A.C., Becker, A.E., Van Der Loos, C.M., Das, P.K. 1994. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques in characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation, 89 (1): 36–44
Wilson, L. M. 2005. Penyakit aterosklerotik koroner. Dalam H. Hartanto, N. Susi, P.
Wulansari, & D.A. Mahanani (Ed.). Patofisiologi
Konsep Klinis Proses-proses Penyakit.
Jakarta:EGC (Original work published 2002)
Kyne, L., Hausdorff, J.M., Kninght, E., Dukas, L., Azhar, G., Wei, J.Y. 2000. Neutrophilia and Congestive Heart Failure After Acute Myocardial Infarction. Am Heart J. 139 (1 Pt 1): 94100.
Setianto, B.Y., Rochmah, W., Nurohman, A. 2003 . Hubungan Angka Leukosit pada Infark Miokard Akut dengan Kejadian Cardiac Event Selama Dirawat di Rumah Sakit. Berkala Ilmu Kedokteran, 35 (1): 31-37.
Widowati, I.,K. 2005, April. Evaluasi terapi obat pada penanganan pasien Infark Miokard Akut di Instalasi Rawat Inap RSUD Kota Yogyakarta tahun 2005. Repository Archive Center UII. Diakses pada 2 April 2009 dari http://rac.uii.ac.id/index.php/ record/view/77516
Baratawidjaja, K. G. 2004. Imunologi Dasar. Jakarta: Balai Penerbit Fakultas Kedokteran Universitas Indonesia.
Wei, J.Y. 2000. Neutrophilia and congestive heart failure after acute MI: Discussion. Diakses pada tangggal 10 november 2009 dari http://www.medscape. com/viewarticle / 409073_4
Yellon, D.M., Hausenloy, D.J. 2007. Mechanisms of Disease Myocardial Reperfusion Injury. New Engl J Med, 357 (11): 1121-1135.
Nader, N. D., Sparlin, J. A. 2008. Neutrophilia. Diakses pada tanggal 5 April 2009 dari http:// emedicine.medscape. com/article/208576overview
Downloads
Published
Issue
Section
License
Copyright
Authors retain copyright and grant Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK) the right of first publication with the work simultaneously licensed under an Attribution 4.0 International (CC BY 4.0) that allows others to remix, adapt and build upon the work with an acknowledgment of the work's authorship and of the initial publication in Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK).
Authors are permitted to copy and redistribute the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK).
License
Articles published in the Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK) are licensed under an Attribution 4.0 International (CC BY 4.0) license. You are free to:
- Share — copy and redistribute the material in any medium or format.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
This license is acceptable for Free Cultural Works. The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.